News About: Pharm. Industry
BMS Korea denies possible M&A as groundless
BMS Korea dismissed an allegation that it is proceeding with the acquisition of a Korean pharmaceutical firm.
An official from BMS Korea said, "It is nothing but a rumor. The company has positively tried to seek a ...
Daewoong Pharm win ISO 14001 certification
Daewoon Pharm said its Hyangnam plant obtained its ISO 14001 certification for an ISO 14001 environmental management system from the U.S. Eagle Co., which is one of the ISO certification agencies and under the managem...
Over 800 items to complete its bio-equivalent tests by year end.
As of June 9 the total number of drugs having completed its bio-equivalency was 604, which will surpass more than 800 items by the end of this year as things are going this way.
The KFDA admitted that such a succes...
Drug wholesalers plagued by dampened business recession
As the national economy is headed downhill with local pharmaceutical business also crumbling, the domestic wholesaling industry is preferably swifting to stable business management instead of targeting preoccupied siz...
Korea's pharmaceutical industry losing competitive edge
Korea's pharmaceutical industry is faced with serious problems with falling competitiveness, and the government needs to employ a series of measures to boost its ability to compete in the global market, indu...
Local pharmaceutical firms eager to find more foreigner partners
Pharmaceutical sources say that more and more pharmaceutical firms are scurrying to seek their foreign partners in the United States, Europe and Japan, as a way to expand their presence in the domestic ethicals market...
Senior researchers shun domestic pharmaceutical industry
Pharmaceutical business sources say that the increasing exodus trend of senior researchers working in domestic pharmaceutical firms will put a wet blanket on the long-term development of the industry.
This unfavora...
GSK to introduce Infanrix DTPa vaccine in Korea
GlaxoSmithKline Korea said that Infanrix DTPa vaccine, which has been widely used all over the world, will be launched in domestic market from June 23 after fulfilling necessary procedures such as state-run tests and ...
Medium-sized pharmaceutical firms turn eyes to new products launching
In a desperate attempt to spark some life into the depressed domestic pharmaceutical market, major medium-sized pharmaceutical firms are launching a variety of their new products to prop up their market shares in para...
Sang-A Pharm seeking to produce generic drugs
Sang-A Pharm said that as part of diversifying its business sector and sales boost, it has recently set up FineChem., a drug synthesis corporation, with a pain-in capital of 500 million won in a bid to meet the increa...
